Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesPayablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Quantum Genesis AI (QTZM) Total Liabilities (2016 - 2026)

Quantumzyme's Total Liabilities history spans 6 years, with the latest figure at $418401.0 for Q1 2026.

  • For Q1 2026, Total Liabilities rose 12.13% year-over-year to $418401.0; the TTM value through Jan 2026 reached $418401.0, up 12.13%, while the annual FY2025 figure was $441301.0, 50.46% up from the prior year.
  • Total Liabilities reached $418401.0 in Q1 2026 per QTZM's latest filing, down from $490769.0 in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $490769.0 in Q4 2025 to a low of $293298.0 in Q3 2024.
  • Average Total Liabilities over 3 years is $394763.4, with a median of $403125.0 recorded in 2025.
  • Peak YoY movement for Total Liabilities: surged 50.46% in 2025, then increased 12.13% in 2026.
  • A 3-year view of Total Liabilities shows it stood at $343322.0 in 2024, then skyrocketed by 42.95% to $490769.0 in 2025, then fell by 14.75% to $418401.0 in 2026.
  • Per Business Quant, the three most recent readings for QTZM's Total Liabilities are $418401.0 (Q1 2026), $490769.0 (Q4 2025), and $441301.0 (Q3 2025).